360 related articles for article (PubMed ID: 24500710)
21. Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction. Evaluation of its role in nitric oxide generation in anoxic tissues.
Li H; Samouilov A; Liu X; Zweier JL
J Biol Chem; 2001 Jul; 276(27):24482-9. PubMed ID: 11312267
[TBL] [Abstract][Full Text] [Related]
22. Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase.
Godber BL; Doel JJ; Sapkota GP; Blake DR; Stevens CR; Eisenthal R; Harrison R
J Biol Chem; 2000 Mar; 275(11):7757-63. PubMed ID: 10713088
[TBL] [Abstract][Full Text] [Related]
23. Study of Different Variants of Mo Enzyme crARC and the Interaction with Its Partners crCytb5-R and crCytb5-1.
Chamizo-Ampudia A; Galvan A; Fernandez E; Llamas A
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335548
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of human mARC1 reveals its exceptional position among eukaryotic molybdenum enzymes.
Kubitza C; Bittner F; Ginsel C; Havemeyer A; Clement B; Scheidig AJ
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):11958-11963. PubMed ID: 30397129
[TBL] [Abstract][Full Text] [Related]
25. Heavy metal ions inhibit molybdoenzyme activity by binding to the dithiolene moiety of molybdopterin in Escherichia coli.
Neumann M; Leimkühler S
FEBS J; 2008 Nov; 275(22):5678-89. PubMed ID: 18959753
[TBL] [Abstract][Full Text] [Related]
26. Cell biology of molybdenum.
Mendel RR
Biofactors; 2009; 35(5):429-34. PubMed ID: 19623604
[TBL] [Abstract][Full Text] [Related]
27. The mitochondrial amidoxime-reducing component (mARC1) is a novel signal-anchored protein of the outer mitochondrial membrane.
Klein JM; Busch JD; Potting C; Baker MJ; Langer T; Schwarz G
J Biol Chem; 2012 Dec; 287(51):42795-803. PubMed ID: 23086957
[TBL] [Abstract][Full Text] [Related]
28. Reduction of sulfamethoxazole hydroxylamine (SMX-HA) by the mitochondrial amidoxime reducing component (mARC).
Ott G; Plitzko B; Krischkowski C; Reichmann D; Bittner F; Mendel RR; Kunze T; Clement B; Havemeyer A
Chem Res Toxicol; 2014 Oct; 27(10):1687-95. PubMed ID: 25170804
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the amidoxime reducing components ARC1 and ARC2 from Arabidopsis thaliana.
Maiber L; Koprivova A; Bender D; Kopriva S; Fischer-Schrader K
FEBS J; 2022 Sep; 289(18):5656-5669. PubMed ID: 35366369
[TBL] [Abstract][Full Text] [Related]
30. Nitrite reductase activity of rat and human xanthine oxidase, xanthine dehydrogenase, and aldehyde oxidase: evaluation of their contribution to NO formation in vivo.
Maia LB; Pereira V; Mira L; Moura JJ
Biochemistry; 2015 Jan; 54(3):685-710. PubMed ID: 25537183
[TBL] [Abstract][Full Text] [Related]
31. The pivotal role of the mitochondrial amidoxime reducing component 2 in protecting human cells against apoptotic effects of the base analog N6-hydroxylaminopurine.
Plitzko B; Havemeyer A; Kunze T; Clement B
J Biol Chem; 2015 Apr; 290(16):10126-35. PubMed ID: 25713076
[TBL] [Abstract][Full Text] [Related]
32. Oxyl and hydroxyl radical transfer in mitochondrial amidoxime reducing component-catalyzed nitrite reduction.
Yang J; Giles LJ; Ruppelt C; Mendel RR; Bittner F; Kirk ML
J Am Chem Soc; 2015 Apr; 137(16):5276-9. PubMed ID: 25897643
[TBL] [Abstract][Full Text] [Related]
33. Evidence for MoeA-dependent formation of the molybdenum cofactor from molybdate and molybdopterin in Escherichia coli.
Sandu C; Brandsch R
Arch Microbiol; 2002 Dec; 178(6):465-70. PubMed ID: 12420167
[TBL] [Abstract][Full Text] [Related]
34. Nitrite-dependent vasodilation is facilitated by hypoxia and is independent of known NO-generating nitrite reductase activities.
Dalsgaard T; Simonsen U; Fago A
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3072-8. PubMed ID: 17307993
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of nitrite bioactivation.
Kim-Shapiro DB; Gladwin MT
Nitric Oxide; 2014 Apr; 38():58-68. PubMed ID: 24315961
[TBL] [Abstract][Full Text] [Related]
36. Nitrite-dependent nitric oxide synthesis by molybdenum enzymes.
Bender D; Schwarz G
FEBS Lett; 2018 Jun; 592(12):2126-2139. PubMed ID: 29749013
[TBL] [Abstract][Full Text] [Related]
37. Molybdenum cofactor and human disease.
Schwarz G
Curr Opin Chem Biol; 2016 Apr; 31():179-87. PubMed ID: 27055119
[TBL] [Abstract][Full Text] [Related]
38. An active site tyrosine influences the ability of the dimethyl sulfoxide reductase family of molybdopterin enzymes to reduce S-oxides.
Johnson KE; Rajagopalan KV
J Biol Chem; 2001 Apr; 276(16):13178-85. PubMed ID: 11278798
[TBL] [Abstract][Full Text] [Related]
39. The molybdenum cofactor biosynthesis protein MobA from Rhodobacter capsulatus is required for the activity of molybdenum enzymes containing MGD, but not for xanthine dehydrogenase harboring the MPT cofactor.
Leimkühler S; Klipp W
FEMS Microbiol Lett; 1999 May; 174(2):239-46. PubMed ID: 10339814
[TBL] [Abstract][Full Text] [Related]
40. The energy-conserving nitric-oxide-reductase system in Paracoccus denitrificans. Distinction from the nitrite reductase that catalyses synthesis of nitric oxide and evidence from trapping experiments for nitric oxide as a free intermediate during denitrification.
Carr GJ; Page MD; Ferguson SJ
Eur J Biochem; 1989 Feb; 179(3):683-92. PubMed ID: 2920732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
